PMID: 6113192Apr 1, 1981Paper

Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer

Gut
R P WaltJ J Misiewicz

Abstract

One hundred and three outpatients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with either cimetidine 200 mg tds and 400 mg nocte, or ranitidine 150 mg bd for four weeks. The endoscopists were not aware of the treatment and took no part in the clinical management. On completion of treatment ulcers had healed in 43 of 51 (84%) patients given cimetidine and in 40 of 52 (77%) patients given ranitidine. There were no serious unwanted effects in either treatment group. The results show no significant difference between healing rates after four weeks of standard cimetidine therapy or ranitidine 150 mg bd.

Citations

Jan 1, 1984·European Journal of Clinical Pharmacology·V F EckardtH Wiemann
Mar 27, 1982·Lancet
Dec 20, 1990·The New England Journal of Medicine·M Feldman, M E Burton
Nov 1, 1989·Gut·G Milton-Thompson
Feb 1, 1983·Postgraduate Medical Journal·F I LeeF T Costello
Nov 1, 1984·Postgraduate Medical Journal·R Doll
Nov 1, 1986·Scandinavian Journal of Gastroenterology·G LuxW Rösch
Jan 1, 1986·Scandinavian Journal of Gastroenterology. Supplement·M LazzaroniG Bianchi Porro
Jan 2, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Alaa Khedr
Mar 1, 1983·Journal of Clinical and Hospital Pharmacy·J DawsonR Cockel
Oct 1, 1982·Australian and New Zealand Journal of Medicine·D B JonesR A Smallwood
Jan 1, 1996·International Journal of Psychiatry in Medicine·K Y KimR Niaura
Aug 30, 1985·The American Journal of Medicine·A L Blum
Feb 13, 1982·British Medical Journal·M G AshtonM Moore
Jan 1, 1983·European Journal of Clinical Pharmacology·K A JönssonA Walan
Oct 1, 1987·Alimentary Pharmacology & Therapeutics·R L McIsaacJ R Wood
Jan 1, 1983·The Journal of International Medical Research·H BrunnerR Pötzi
Jan 1, 1986·Scandinavian Journal of Gastroenterology. Supplement·P BauerfeindA L Blum
May 1, 1986·Journal of Clinical Pharmacology·E W CateJ R Powell
Dec 1, 1983·Drug Intelligence & Clinical Pharmacy·T S Gaginella, J H Bauman
Oct 15, 1985·Klinische Wochenschrift·P MalfertheinerH Ditschuneit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.